Traws Pharma, Inc. Common Stock (TRAW)
Traws Pharma, Inc. (TRAW) is a biotechnology company focusing on the development of innovative pharmaceutical products. The company is dedicated to researching and bringing to market therapies aimed at addressing unmet medical needs, with a particular emphasis on novel formulations and delivery systems. Traws Pharma aims to leverage cutting-edge science to improve patient outcomes across various therapeutic areas.
Company News
Traws Pharma, a clinical-stage biopharmaceutical company, is developing novel antiviral therapies targeting respiratory viral diseases like bird flu, seasonal influenza, and COVID-19. The company submitted a Phase 2 protocol for tivoxavir marboxil and briefing documents to the FDA for a Type D meeting.
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 75% and 6.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Shares of Flora Growth Corp. (NASDAQ: FLGC) fell sharply in today’s pre-market trading after the company reported the launch of proposed underwritten public offering of common shares. Flora Growth shares tumbled 20.2% to $2.13 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers HWH International Inc. (NASD...